Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Bristol Should Have Opdivo First-Line Lung Cancer Data In Weeks

Jul 29 2016

• By Emily Hayes

Related Content

Merck Poised To Be First To Market With A PD-1 For First-Line Lung Cancer

Jun 16 2016

Bristol's HCV Bump Catalyzes Strong Quarter, But Not Expected To Last

Jul 29 2016

Bristol's Oncology Strategy: Cover All The Bases To Keep The Lead

Jul 04 2016

Bristol Pushes Pedal To Metal In Immuno-Oncology Combo Testing

Jul 04 2016

Related Companies

Bristol Myers Squibb Company

Merck & Co., Inc.

Cormorant Pharmaceuticals

Additional Topics

Research & Development Business Strategies Commercial Companies Cancer BioPharmaceutical

More from Anticancer

More from Therapy Areas

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window